tiprankstipranks
Advertisement
Advertisement
Cullinan Therapeutics sees cash runway into 2029
PremiumThe FlyCullinan Therapeutics sees cash runway into 2029
16d ago
CGEM Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CGEM Upcoming Earnings Report: What to Expect?
23d ago
TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
Premium
Market News
TheStreet Pro Analysts Say, “It’s a Stock Picker’s Market – Here Are 4 to Consider”
1M ago
Cullinan Therapeutics initiated with a Buy at Guggenheim
PremiumThe FlyCullinan Therapeutics initiated with a Buy at Guggenheim
2M ago
Cullinan: Buy Rating Reiterated on 2026 Clinical Catalysts and Undervalued Pipeline Upside
Premium
Ratings
Cullinan: Buy Rating Reiterated on 2026 Clinical Catalysts and Undervalued Pipeline Upside
3M ago
Cullinan Therapeutics price target raised to $27 from $26 at H.C. Wainwright
Premium
The Fly
Cullinan Therapeutics price target raised to $27 from $26 at H.C. Wainwright
3M ago
Cullinan Therapeutics price target raised to $34 from $25 at Wedbush
PremiumThe FlyCullinan Therapeutics price target raised to $34 from $25 at Wedbush
4M ago
Buy Rating for Cullinan Management Driven by Promising CLN-049 Clinical Data and Strategic Development Plan
Premium
Ratings
Buy Rating for Cullinan Management Driven by Promising CLN-049 Clinical Data and Strategic Development Plan
4M ago
Promising Outlook for Cullinan Management: Buy Rating Backed by Strong Therapeutic Developments and Financial Position
Premium
Ratings
Promising Outlook for Cullinan Management: Buy Rating Backed by Strong Therapeutic Developments and Financial Position
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100